Author: John J Cush
Publisher: Elsevier Health Sciences
ISBN: 145575059X
Category : Medical
Languages : en
Pages : 183
Book Description
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
Author: John J Cush
Publisher: Elsevier Health Sciences
ISBN: 145575059X
Category : Medical
Languages : en
Pages : 183
Book Description
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
Publisher: Elsevier Health Sciences
ISBN: 145575059X
Category : Medical
Languages : en
Pages : 183
Book Description
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
Update on Osteoarthritis, An Issue of Rheumatic Disease Clinics
Author: David J. Hunter
Publisher: Elsevier Health Sciences
ISBN: 1455773557
Category : Medical
Languages : en
Pages : 414
Book Description
Guest edited by David Hunter, this issue of Rheumatic Disease Clinics provides an update on the latest diagnosis, treatment and long-term management strategies for osteoarthritis. Topics to be covered include pathogenesis, joint mechanics, imaging of osteoarthritis, muscle and disease genesis, disease modification, and surgical strategies for treatment.
Publisher: Elsevier Health Sciences
ISBN: 1455773557
Category : Medical
Languages : en
Pages : 414
Book Description
Guest edited by David Hunter, this issue of Rheumatic Disease Clinics provides an update on the latest diagnosis, treatment and long-term management strategies for osteoarthritis. Topics to be covered include pathogenesis, joint mechanics, imaging of osteoarthritis, muscle and disease genesis, disease modification, and surgical strategies for treatment.
Spondyloarthropathies, An Issue of Rheumatic Disease Clinics
Author: Juergen Braun
Publisher: Elsevier Health Sciences
ISBN: 1455750603
Category : Medical
Languages : en
Pages : 236
Book Description
Edited by Drs. Juergen Braun and Joachim Sieper, this issue of Rheumatic Disease Clinics comprehensively reviews the state of the art of spondyloarthritis (SpA) diagnosis, prognosis, pathogenesis and genetic insights, and treatment. The worldwide burden of SpA now exceeds that of rheumatoid arthritis. General topics covered include inflammatory back pain, pathophysiology, imaging techniques, and therapeutic strategies.
Publisher: Elsevier Health Sciences
ISBN: 1455750603
Category : Medical
Languages : en
Pages : 236
Book Description
Edited by Drs. Juergen Braun and Joachim Sieper, this issue of Rheumatic Disease Clinics comprehensively reviews the state of the art of spondyloarthritis (SpA) diagnosis, prognosis, pathogenesis and genetic insights, and treatment. The worldwide burden of SpA now exceeds that of rheumatoid arthritis. General topics covered include inflammatory back pain, pathophysiology, imaging techniques, and therapeutic strategies.
Rheumatic Rarities, An Issue of Rheumatic Disease Clinics
Author: Jonathan Kay
Publisher: Elsevier Health Sciences
ISBN: 1455773840
Category : Medical
Languages : en
Pages : 368
Book Description
Guest edited by Jonathan Kay, this issue of Rheumatic Disease Clinics will cover the latest research and evidence surrounding the diagnosis, treatment and management of rarely seen rheumatic diseases.
Publisher: Elsevier Health Sciences
ISBN: 1455773840
Category : Medical
Languages : en
Pages : 368
Book Description
Guest edited by Jonathan Kay, this issue of Rheumatic Disease Clinics will cover the latest research and evidence surrounding the diagnosis, treatment and management of rarely seen rheumatic diseases.
The Use of Imaging in Inflammatory Joint and Vascular Disorders, An Issue of Rheumatic Disease Clinics
Author: Stephen A. Paget
Publisher: Elsevier Health Sciences
ISBN: 1455773565
Category : Medical
Languages : en
Pages : 338
Book Description
This issue of Rheumatic Disease Clinics teaches you the latest best practices for using musculoskeletal ultrasound to diagnose and monitor the progression of rheumatoid arthritis, vasculitis, and other rheumatic and soft tissue disorders.
Publisher: Elsevier Health Sciences
ISBN: 1455773565
Category : Medical
Languages : en
Pages : 338
Book Description
This issue of Rheumatic Disease Clinics teaches you the latest best practices for using musculoskeletal ultrasound to diagnose and monitor the progression of rheumatoid arthritis, vasculitis, and other rheumatic and soft tissue disorders.
Highlights of Interdisciplinary Care in Rheumatology, An Issue of Rheumatic Disease Clinics of North America
Author: Anisha Dua
Publisher: Elsevier Health Sciences
ISBN: 0443343667
Category : Medical
Languages : en
Pages : 278
Book Description
In this issue of Rheumatic Disease Clinics, guest editors Anisha Dua and Jeffery A. Sparks bring their considerable expertise to the topic of Interdisciplinary Care in Rheumatology. Top experts in the field cover key topics such as Systemic Diseases and Heart Block; Prospects of Disease-Modifying Osteoarthritis Drugs; The Role of Psychology in Pediatric Rheumatic Diseases; and more. - Contains 10 relevant, practice-oriented topics including Imaging of Pulmonary Manifestations of Connective Tissue Disease; Connective Tissue Disease Associated Interstitial Lung Disease; Newer Immunosuppressants for Rheumatologic Disease; and more. - Provides in-depth clinical reviews on Interdisciplinary care, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Publisher: Elsevier Health Sciences
ISBN: 0443343667
Category : Medical
Languages : en
Pages : 278
Book Description
In this issue of Rheumatic Disease Clinics, guest editors Anisha Dua and Jeffery A. Sparks bring their considerable expertise to the topic of Interdisciplinary Care in Rheumatology. Top experts in the field cover key topics such as Systemic Diseases and Heart Block; Prospects of Disease-Modifying Osteoarthritis Drugs; The Role of Psychology in Pediatric Rheumatic Diseases; and more. - Contains 10 relevant, practice-oriented topics including Imaging of Pulmonary Manifestations of Connective Tissue Disease; Connective Tissue Disease Associated Interstitial Lung Disease; Newer Immunosuppressants for Rheumatologic Disease; and more. - Provides in-depth clinical reviews on Interdisciplinary care, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Pediatric Rheumatology Comes of Age: Part II, An Issue of Rheumatic Disease Clinics of North America, E-Book
Author: Laura E. Schanberg︎
Publisher: Elsevier Health Sciences
ISBN: 0323848818
Category : Medical
Languages : en
Pages : 417
Book Description
In this issue of Rheumatic Disease Clinics, Guest Editors Laura E. Schanberg? MD and Yukiko Kimura? MD brings his considerable expertise to the topic of pediatric rheumatology. Top experts in the field cover key topics such as CARRA, Mental health, Social media and JIA, CV disease in PRD, and more. - Provides in-depth, clinical reviews on pediatric rheumatology, providing actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. - Contains 20 relevant, practice-oriented topics, such as Pharmacosurveillance of biologics in pediatric rheumatic disease (or JIA); cSLE in developing countries: impact of access to care, ethnic differences?; Biomarkers and Outcome Measures in cSLE; Role of environment on PRD; and more.
Publisher: Elsevier Health Sciences
ISBN: 0323848818
Category : Medical
Languages : en
Pages : 417
Book Description
In this issue of Rheumatic Disease Clinics, Guest Editors Laura E. Schanberg? MD and Yukiko Kimura? MD brings his considerable expertise to the topic of pediatric rheumatology. Top experts in the field cover key topics such as CARRA, Mental health, Social media and JIA, CV disease in PRD, and more. - Provides in-depth, clinical reviews on pediatric rheumatology, providing actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. - Contains 20 relevant, practice-oriented topics, such as Pharmacosurveillance of biologics in pediatric rheumatic disease (or JIA); cSLE in developing countries: impact of access to care, ethnic differences?; Biomarkers and Outcome Measures in cSLE; Role of environment on PRD; and more.
Clinical Innovation in Rheumatology
Author: Jason Liebowitz
Publisher: CRC Press
ISBN: 1000684768
Category : Medical
Languages : en
Pages : 434
Book Description
Tremendous advances have been made in the field of rheumatology, profoundly changing our understanding of many rheumatologic conditions and creating a new frontier for effective treatments. This book explains the most significant advances in research and care and speculates as to what will be the future of rheumatology over the next several decades, including challenges and lessons learned from past experiences in the field. It highlights landmark research articles and scientific discoveries, discusses how big data, personalized medicine, new biomarkers for disease, and other technological revolutions will shape the future, making it a must-have resource for physicians from all regions of the world. Key Features • Includes concise yet thorough description of the landmark studies and scientific breakthroughs coupled with easy-to-follow organizational structure of chapters that are accessible to readers at different levels of training. • Brings together world-leading experts to provide a fresh perspective to trainees such as residents and fellows-in-training, as well as more senior clinicians and researchers across the field of rheumatology and in specialties such as cardiology, dermatology, pulmonology, nephrology, and neurology, all of whom care for patients with rheumatologic conditions. • Allows the authors to imagine and speculate about the evolution of the field of rheumatology in the coming decades. Examples of such speculative possibilities include use of synovial biopsy to predict response to treatment in rheumatoid arthritis, replacement of renal biopsy with urinary proteomics in diagnosing and classifying lupus nephritis, use of new therapeutics to obviate the need for steroids in the treatment of ANCA-associated vasculitis, and the use of machine learning to evaluate subtle changes in imaging for management of inflammatory arthritis.
Publisher: CRC Press
ISBN: 1000684768
Category : Medical
Languages : en
Pages : 434
Book Description
Tremendous advances have been made in the field of rheumatology, profoundly changing our understanding of many rheumatologic conditions and creating a new frontier for effective treatments. This book explains the most significant advances in research and care and speculates as to what will be the future of rheumatology over the next several decades, including challenges and lessons learned from past experiences in the field. It highlights landmark research articles and scientific discoveries, discusses how big data, personalized medicine, new biomarkers for disease, and other technological revolutions will shape the future, making it a must-have resource for physicians from all regions of the world. Key Features • Includes concise yet thorough description of the landmark studies and scientific breakthroughs coupled with easy-to-follow organizational structure of chapters that are accessible to readers at different levels of training. • Brings together world-leading experts to provide a fresh perspective to trainees such as residents and fellows-in-training, as well as more senior clinicians and researchers across the field of rheumatology and in specialties such as cardiology, dermatology, pulmonology, nephrology, and neurology, all of whom care for patients with rheumatologic conditions. • Allows the authors to imagine and speculate about the evolution of the field of rheumatology in the coming decades. Examples of such speculative possibilities include use of synovial biopsy to predict response to treatment in rheumatoid arthritis, replacement of renal biopsy with urinary proteomics in diagnosing and classifying lupus nephritis, use of new therapeutics to obviate the need for steroids in the treatment of ANCA-associated vasculitis, and the use of machine learning to evaluate subtle changes in imaging for management of inflammatory arthritis.
Treatment Guideline Development and Implementation, An Issue of Rheumatic Disease Clinics of North America, E-Book
Author: Michael Ward
Publisher: Elsevier Health Sciences
ISBN: 0323960499
Category : Medical
Languages : en
Pages : 201
Book Description
In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Publisher: Elsevier Health Sciences
ISBN: 0323960499
Category : Medical
Languages : en
Pages : 201
Book Description
In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Changing Health Care Systems and Rheumatic Disease
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309056837
Category : Medical
Languages : en
Pages : 253
Book Description
Market forces are driving a radical restructuring of health care delivery in the United States. At the same time, more and more people are living comparatively long lives with a variety of severe chronic health conditions. Many such people are concerned about the trend toward the creation of managed care systems because their need for frequent, often complex, medical services conflicts with managed care's desires to contain costs. The fear is that people with serious chronic disorders will be excluded from or underserved by the integrated health care delivery networks now emerging. Responding to a request from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, this book reflects the results of a workshop that focused on the following questions: Does the model of managed care or an integrated delivery system influence the types of interventions provided to patients with chronic conditions and the clinical and health status outcomes resulting from those interventions? If so, are these effects quantitatively and clinically significant, as compared to the effects that other variables (e.g., income, education, ethnicity) have on patient outcomes? If the type of health care delivery system appears to be related to patient care and outcomes, can specific organizational, financial, or other variables be identified that account for the relationships? If not, what type of research should be pursued to provide the information needed about the relationship between types of health care systems and the processes and outcomes of care provided to people with serious chronic conditions?
Publisher: National Academies Press
ISBN: 0309056837
Category : Medical
Languages : en
Pages : 253
Book Description
Market forces are driving a radical restructuring of health care delivery in the United States. At the same time, more and more people are living comparatively long lives with a variety of severe chronic health conditions. Many such people are concerned about the trend toward the creation of managed care systems because their need for frequent, often complex, medical services conflicts with managed care's desires to contain costs. The fear is that people with serious chronic disorders will be excluded from or underserved by the integrated health care delivery networks now emerging. Responding to a request from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, this book reflects the results of a workshop that focused on the following questions: Does the model of managed care or an integrated delivery system influence the types of interventions provided to patients with chronic conditions and the clinical and health status outcomes resulting from those interventions? If so, are these effects quantitatively and clinically significant, as compared to the effects that other variables (e.g., income, education, ethnicity) have on patient outcomes? If the type of health care delivery system appears to be related to patient care and outcomes, can specific organizational, financial, or other variables be identified that account for the relationships? If not, what type of research should be pursued to provide the information needed about the relationship between types of health care systems and the processes and outcomes of care provided to people with serious chronic conditions?